Literature DB >> 21953338

Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern.

Aurélie Ambrosi1, Stina Salomonsson, Håkan Eliasson, Elisabeth Zeffer, Amanda Skog, Vijole Dzikaite, Gunnar Bergman, Eva Fernlund, Joanna Tingström, Elke Theander, Annika Rydberg, Thomas Skogh, Annika Öhman, Ulla Lundström, Mats Mellander, Ola Winqvist, Michael Fored, Anders Ekbom, Lars Alfredsson, Henrik Källberg, Tomas Olsson, Fredrik Gadler, Anders Jonzon, Ingrid Kockum, Sven-Erik Sonesson, Marie Wahren-Herlenius.   

Abstract

OBJECTIVE: Congenital heart block may develop in the fetuses of Ro/SSA-positive and La/SSB-positive mothers. Recurrence rates of only 10-20% despite persisting maternal antibodies indicate that additional factors are critical for the establishment of heart block. The authors investigated the influence of other maternal and fetal factors on heart block development in a Swedish population-based cohort.
METHODS: The influence of fetal gender, maternal age, parity and time of birth on heart block development was analysed in 145 families, including Ro/La-positive (n=190) and Ro/La-negative (n=165) pregnancies.
RESULTS: There was a recurrence rate of 12.1% in Ro/La-positive women, and no recurrence in Ro/La-negative women. Fetal gender and parity did not influence the development of heart block in either group. Maternal age in Ro/La-positive pregnancies with a child affected by heart block was, however, significantly higher than in pregnancies resulting in babies without heart block (p<0.05).Seasonal timing of pregnancy influenced the outcome. Gestational susceptibility weeks 18-24 occurring during January-March correlated with a higher proportion of children with heart block and lower vitamin D levels during the same period in a representative sample of Swedish women and a corresponding higher proportion of children with heart block born in the summer (p<0.02). Maternal age or seasonal timing of pregnancy did not affect the outcome in Ro/La-negative pregnancies.
CONCLUSION: This study identifies maternal age and seasonal timing of pregnancy as novel risk factors for heart block development in children of Ro/La-positive women. These observations may be useful for counselling when pregnancy is considered.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21953338     DOI: 10.1136/annrheumdis-2011-200207

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus.

Authors:  Peter M Izmirly; Nathalie Costedoat-Chalumeau; Cecilia N Pisoni; Munther A Khamashta; Mimi Y Kim; Amit Saxena; Deborah Friedman; Carolina Llanos; Jean-Charles Piette; Jill P Buyon
Journal:  Circulation       Date:  2012-05-24       Impact factor: 29.690

2.  Serum Biomarkers of Inflammation, Fibrosis, and Cardiac Function in Facilitating Diagnosis, Prognosis, and Treatment of Anti-SSA/Ro-Associated Cardiac Neonatal Lupus.

Authors:  Amit Saxena; Peter M Izmirly; Sung Won Han; Paraskevi Briassouli; Tania L Rivera; Hua Zhong; Deborah M Friedman; Robert M Clancy; Jill P Buyon
Journal:  J Am Coll Cardiol       Date:  2015-08-25       Impact factor: 24.094

Review 3.  Autoantibodies in Sjögren's Syndrome.

Authors:  Anum Fayyaz; Biji T Kurien; R Hal Scofield
Journal:  Rheum Dis Clin North Am       Date:  2016-06-21       Impact factor: 2.670

Review 4.  Diagnosis and treatment of fetal arrhythmia.

Authors:  Annette Wacker-Gussmann; Janette F Strasburger; Bettina F Cuneo; Ronald T Wakai
Journal:  Am J Perinatol       Date:  2014-05-23       Impact factor: 1.862

Review 5.  Update on Pathogenesis of Sjogren's Syndrome.

Authors:  Pulukool Sandhya; Biji Theyilamannil Kurien; Debashish Danda; Robert Hal Scofield
Journal:  Curr Rheumatol Rev       Date:  2017

6.  Pregnancy outcome of 126 anti-SSA/Ro-positive patients during the past 24 years--a retrospective cohort study.

Authors:  Yan Luo; Lili Zhang; Yunyun Fei; Yiqun Li; Donglin Hao; Yi Liu; Yan Zhao
Journal:  Clin Rheumatol       Date:  2015-08-26       Impact factor: 2.980

7.  Prognostic value of Sjögren's syndrome autoantibodies.

Authors:  R Hal Scofield; Anum Fayyaz; Biji T Kurien; Kristi A Koelsch
Journal:  J Lab Precis Med       Date:  2018-10-30

Review 8.  Neonatal lupus: advances in understanding pathogenesis and identifying treatments of cardiac disease.

Authors:  Peter M Izmirly; Jill P Buyon; Amit Saxena
Journal:  Curr Opin Rheumatol       Date:  2012-09       Impact factor: 5.006

9.  Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers.

Authors:  Peter Izmirly; Mimi Kim; Deborah M Friedman; Nathalie Costedoat-Chalumeau; Robert Clancy; Joshua A Copel; Colin K L Phoon; Bettina F Cuneo; Rebecca E Cohen; Kimberly Robins; Mala Masson; Benjamin J Wainwright; Noel Zahr; Amit Saxena; Jill P Buyon
Journal:  J Am Coll Cardiol       Date:  2020-07-21       Impact factor: 24.094

10.  Identification of discrete epitopes of Ro52p200 and association with fetal cardiac conduction system manifestations in a rodent model.

Authors:  A Hoxha; A Ruffatti; A Ambrosi; V Ottosson; M Hedlund; L Ottosson; M Anandapadamanaban; M Sunnerhagen; S-E Sonesson; M Wahren-Herlenius
Journal:  Clin Exp Immunol       Date:  2016-09-13       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.